Resources
December 5, 2024 1:00 – 2:00pm ET Register >> In today’s complex healthcare landscape, going beyond traditional data is essential. Join our exclusive webinar to discover how scaling qualitative data from clinical notes, combined with AI, can reveal hidden patterns in patient journeys and treatment drivers, giving you a complete view of your therapy’s impact. Explore[…]
Tuesday, November 19, 2024 2:00-3:00PM ET Register >> Clinical trial recruitment remains a major bottleneck for the pharmaceutical industry, with 85% of trials struggling to meet participant targets despite nearly $1.9 billion spent annually. The financial stakes are high, with trial delays, primarily due to patient recruitment costing companies between $600K to $8M per day.[…]
Read the full press release >> ROSEMONT, Ill. (Oct. 30, 2024) — A new initiative by the American Academy of Dermatology aims to shed light on an often misunderstood and debilitating condition, hidradenitis suppurativa (HS). HS is a chronic progressive condition that can cause painful and boil-like bumps, particularly in a patient’s armpits, thighs, and groin.[…]
Pharmaceutical Executive October 25, 2024 Read the full article >> Despite a recent FDA Complete Response Letter issued to Lykos for midomafetamine capsules for the treatment of post-traumatic stress disorder, experts believe that the future is bright for psychedelic drugs that treat mental health conditions. On August 9, 2024, the FDA announced that it had[…]
ISPOR Europe When: November 17-20 Where: Barcelona, Spain Booth # 1207 OM1 will be at 2024 ISPOR Europe! Our clinical expertise and integrated evidence approach bring together real-world data, AI, and automated, regulatory-enabled platforms to help researchers fill in gaps along the patient journey from bench to bedside. Presentation Title: Harnessing AI to Better Understand[…]
